# OnCo record caroline-robert (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/caroline-robert/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "caroline-robert" ;
  schema:name "Caroline Robert"@en ;
  schema:description "Led KEYNOTE-006 and COMBI-v, the trials that made pembrolizumab and dabrafenib-trametinib standards in melanoma."@en ;
  schema:url <https://onco.cc/people/caroline-robert/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Robert%20C%5BAuthor%5D%20melanoma%20pembrolizumab> ;
  onco:tag "melanoma", "immunotherapy", "trialist" ;
  schema:jobTitle "Head of Dermatology Unit, Gustave Roussy; Professor, Paris-Saclay University" ;
  schema:sameAs <https://orcid.org/0000-0002-9493-0238> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/braf/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/> ;
  onco:institutions <https://onco.cc/institutions/gustave-roussy/> ;
  onco:trials <https://onco.cc/trials/keynote-006/> ;
  schema:affiliation <https://onco.cc/institutions/gustave-roussy/> .